ALBANY, N.Y.--(BUSINESS WIRE)--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the 30th Annual Canaccord Genuity Growth Conference in Boston on Thursday, August 12, 2010, at 1 p.m. Eastern Time. Jan Keltjens, President and CEO, will review the Company’s business strategy and historical financial results.
